4 March 2021 - An Auckland paediatric neurologist says PHARMAC's decision to switch to a generic version of an epilepsy drug in 2019 cannot be discounted as a cause of death.
Dr Cynthia Sharpe's comments come as part of the coronial inquest, led by Chief Coroner Deborah Marshall, into the deaths of six people who had switched to the drug known as Logem.